FindTrial
Sign In

Pediatric epstein-barr virus-associated hemophagocytic lymphohistiocytosis: a prospective cohort study

Pediatric epstein-barr virus-associated hemophagocytic lymphohistiocytosis: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054915
Enrollment
Unknown
Registered
2021-12-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epstein-Barr virus-associated hemophagocytic syndrome

Interventions

EBV group:No
EBV-HLH group:No

Sponsors

Hu'nan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. EBV cohort: <= 18 years old; confirmed EBV acute infection or CAEBV through serological or EBDNA tests. 2. EBV-HLH cohort: <= 18 years old; confirmed EBV acute infection or CAEBV; meet the HLH-2004 diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. EBV cohort: insufficient evidence for EBV infection. 2. EBV-HLH cohort: insufficient evidence for EBV infection; or missing original diagnose record.

Design outcomes

Primary

MeasureTime frame
30-day survival;—

Countries

China

Contacts

Public ContactLu Xiulan

Hu'nan Children's Hospital

13787252674@163.com+86 13787252674

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026